Varian Down 18% From 2020 Peak, 15% Gain Possible Post-Covid?

Varian Medical stock has rallied around 34% over recent weeks (vs. about a 36% gain in the S&P 500) to its current level of $120, after falling to a low of $90 in late March as a rapid increase in the number of Covid-19 cases outside China resulted in heightened fears of an imminent global economic.

About the Author

has written 23400 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com